Skip to main content
Fig. 1 | BMC Medical Research Methodology

Fig. 1

From: Handling informative dropout in longitudinal analysis of health-related quality of life: application of three approaches to data from the esophageal cancer clinical trial PRODIGE 5/ACCORD 17

Fig. 1

Patients who dropped out after visits V0 to V6, or did not drop out (V7). Legend: Ratio calculated by treatment arm in evaluable patients for each of the four dimensions of EORTC QLQ-C30 (QL, global health status; PF, physical functioning; PA, pain; and FA, fatigue) during radiochemotherapy (RT), chemotherapy (CT), and follow-up visits (V)

Back to article page